CRP and systemic sclerosis: Previous studies in chronic disease have demonstrated the ability of CRP to predict cardiovascular events in patients with arteriosclerotic diseases [34], treatment failure in tuberculosis [35] or human immunodeficiency virus infection [36], and disease progression in ILD with systemic scleroderma [37].